EICHOR
● Active Not Recruiting
Screening for High Frequency Malignant Disease
Condition: Lung Cancer · Sponsor: Guardant Health, Inc.
About this study
The SHIELD (Screening for High Frequency Malignant Disease) study is a prospective, observational, multi-site basket design trial without randomization. The primary objective of the study is to evaluate the sensitivity and specificity of a blood-based GuardantLUNAR-2 test to detect high frequency cancer in screen-relevant populations.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (143)
| University of Alabama Birmingham Lung Health Center | Birmingham, Alabama, United States | — |
| Highlands Oncology Group PA | Fayetteville, Arkansas, United States | — |
| Pacific Cancer Medical Center | Anaheim, California, United States | — |
| Providence St. Joseph Hospital Eureka Cancer Program | Eureka, California, United States | — |
| SoCal Clinical Research | Fountain Valley, California, United States | — |
| Advanced Investigative Medicine | Hawthorne, California, United States | — |
| Cedars-Sinai Medical Center | Los Angeles, California, United States | — |
| California Medical Research Associates Inc. | Northridge, California, United States | — |
| Providence Medical Foundation | Santa Rosa, California, United States | — |
| Starling Physicians | New Britain, Connecticut, United States | — |
| George Washington University Medical Center | Washington D.C., District of Columbia, United States | — |
| Central Florida Pulmonary Group, P.A. | Altamonte Springs, Florida, United States | — |
+ 131 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05117840